Evidence map›Paper›PMID 34852229›Full record

ArticleCell reports2021

Altered H3 histone acetylation impairs high-fidelity DNA repair to promote cerebellar degeneration in spinocerebellar ataxia type 7.

Pawel M Switonski, Joe R Delaney, Luke C Bartelt, Chenchen Niu, Maria Ramos-Zapatero, Nathanael J Spann, Akshay Alaghatta, Toby Chen, Emily N Griffin, Jaidev Bapat and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Pawel M SwitonskiDepartments of Pathology & Laboratory Medicine, Neurology, and Biological Chemistry, University of California, Irvine, Irvine, CA 92697, USA; Department of Neurology, Duke University School of Medicine, Durham, NC 27710, USA; Department of Medical Biotechnology, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14 Str., 61-704 Poznan, Poland.
Joe R DelaneyDepartment of Neurology, Duke University School of Medicine, Durham, NC 27710, USA.
Luke C BarteltDepartment of Neurology, Duke University School of Medicine, Durham, NC 27710, USA.
Chenchen NiuDepartments of Pathology & Laboratory Medicine, Neurology, and Biological Chemistry, University of California, Irvine, Irvine, CA 92697, USA.
Maria Ramos-ZapateroDepartment of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA.
Nathanael J SpannDepartment of Cellular & Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Akshay AlaghattaDepartment of Neurology, Duke University School of Medicine, Durham, NC 27710, USA.
Toby ChenDepartment of Neurology, Duke University School of Medicine, Durham, NC 27710, USA.
Emily N GriffinDepartment of Cellular & Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Jaidev BapatDepartment of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA.
Bryce L SopherDepartment of Neurology, University of Washington Medical Center, Seattle, WA 98195, USA.
Albert R La SpadaDepartments of Pathology & Laboratory Medicine, Neurology, and Biological Chemistry, University of California, Irvine, Irvine, CA 92697, USA; Department of Neurology, Duke University School of Medicine, Durham, NC 27710, USA; UCI Institute for Neurotherapeutics, University of California, Irvine, Irvine, CA 92697, USA. Electronic address: alaspada@uci.edu.
Duke University · USUniversity of California San Diego · USUniversity of California, Irvine · USUniversity of Washington Medical Center · US

Funding

Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PETER J TONTONOZ · 2003 to 2026
$40.4M
SCA7 RETINAL DEGENERATION: MOLECULAR BASIS &THERAPYR01EY014061 · NEI · UNIVERSITY OF WASHINGTON · PI ALBERT R LA SPADA · 2002 to 2026
$8.4M
La Spada Outstanding Investigator AwardR35NS122140 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI ALBERT R LA SPADA · 2021 to 2026
$7.2M
Molecular genetic regulation of autophagy in health and neurodegenerative diseaseR01AG033082 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LA SPADA, ALBERT R · 2009 to 2019
$4.0M
Genetics and Genomics Training GrantT32GM136627 · NIGMS · DUKE UNIVERSITY · PI ALLISON E ASHLEY-KOCH · 2020 to 2026
$3.1M
Copy Number Alterations in Low Mutation CancerK99CA207729 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DELANEY, JOE R · 2017 to 2018
$230k
NCI NIH HHS K99 CA207729NEI NIH HHS R01 EY014061NIA NIH HHS R01 AG033082NIDDK NIH HHS P30 DK063491NIGMS NIH HHS T32 GM136627NINDS NIH HHS R35 NS122140
6 · The paper itself

Abstract

A common mechanism in inherited ataxia is a vulnerability of DNA damage. Spinocerebellar ataxia type 7 (SCA7) is a CAG-polyglutamine-repeat disorder characterized by cerebellar and retinal degeneration. Polyglutamine-expanded ataxin-7 protein incorporates into STAGA co-activator complex and interferes with transcription by altering histone acetylation. We performed chromatic immunoprecipitation sequencing ChIP-seq on cerebellum from SCA7 mice and observed increased H3K9-promoter acetylation in DNA repair genes, resulting in increased expression. After detecting increased DNA damage in SCA7 cells, mouse primary cerebellar neurons, and patient stem-cell-derived neurons, we documented reduced homology-directed repair (HDR) and single-strand annealing (SSA). To evaluate repair at endogenous DNA in native chromosome context, we modified linear amplification-mediated high-throughput genome-wide translocation sequencing and found that DNA translocations are less frequent in SCA7 models, consistent with decreased HDR and SSA. Altered DNA repair function in SCA7 may predispose the subject to excessive DNA damage, leading to neuron demise and highlights DNA repair as a therapy target.

Indexed as

DNA RepairAcetylationAnimalsAtaxin-7Cerebellar DiseasesFemaleHistonesHumansMaleMiceNeuronsPeptidesSpinocerebellar AtaxiasAtaxin-7HistonesPeptidespolyglutamineataxin-7cerebellumChIP-seqDNA damageepigenetic dysregulationneurodegenerationpolyglutaminerepairspinocerebellar ataxiatranslocation

Identifiers

PMID34852229
PMCPMC8710427
OpenAlexW3217440080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.